Myeloid-conditioning using Toll-like receptor agonists to restore immune potency against melanoma.

被引:0
|
作者
Foureau, David [1 ,2 ]
Carpenter, Kendall [1 ]
Amin, Asim [3 ]
Guo, Fei [2 ]
White, Richard [4 ]
Salo, Jonathan [4 ]
机构
[1] Carolinas Healthcare Syst, Gen Surg Res, Charlotte, NC USA
[2] Carolinas Healthcare Syst, Immune Monitoring Core Lab, Charlotte, NC USA
[3] Carolinas Healthcare Syst, Levine Canc Inst, Charlotte, NC USA
[4] Carolinas Healthcare Syst, Surg Oncol, Charlotte, NC USA
来源
JOURNAL OF IMMUNOLOGY | 2014年 / 192卷
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
TUM4P.926
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Influenza vaccines using liposomal formulations of toll-like receptor (TLR) 7/8 and 4 agonists as adjuvants
    Cole, Shelby L.
    Cybulski, Van A.
    Whitacre, Margaret
    Lathrop, Stephanie K.
    Bazin-Lee, Helene
    Burkhart, David
    Evans, Jay T.
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [42] Early immune responses in skin and lymph node after skin delivery of Toll-like receptor agonists in neonatal and adult pigs
    Vreman, Sandra
    Rebel, Johanna M. J.
    McCaffrey, Joanne
    Ledl, Kristina
    Arkhipova, Ksenia
    Collins, Damien
    McDaid, Dennis
    Savelkoul, Huub F. J.
    Skovgaard, Kerstin
    Moore, Anne C.
    Stockhofe-Zurwieden, Norbert
    VACCINE, 2021, 39 (13) : 1857 - 1869
  • [43] Toll-like receptor-based adjuvants: enhancing the immune response to vaccines against infectious diseases of chicken
    Gupta, Shishir Kumar
    Deb, Rajib
    Dey, Sohini
    Chellappa, Madhan Mohan
    EXPERT REVIEW OF VACCINES, 2014, 13 (07) : 909 - 925
  • [44] Contrasting Mechanisms of Interferon-α Inhibition by Intravenous Immunoglobulin After Induction by Immune Complexes Versus Toll-like Receptor Agonists
    Wiedeman, Alice E.
    Santer, Deanna M.
    Yan, Wei
    Miescher, Sylvia
    Kaesermann, Fabian
    Elkon, Keith B.
    ARTHRITIS AND RHEUMATISM, 2013, 65 (10): : 2713 - 2723
  • [45] The Combination of Ionizing Radiation and Toll-Like Receptor 7/8 Agonists Creates Local and Abscopal Tumor Immune Responses In Vivo
    Nicolay, N. H.
    Schoelch, S.
    Rauber, C.
    Perez, R. Lopez
    Debus, J.
    Huber, P. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E561 - E561
  • [46] Innate immune responses after stimulation with Toll-like receptor agonists in ex vivo microglial cultures and an in vivo model using mice with reduced microglia
    James A. Carroll
    Brent Race
    Katie Williams
    James F. Striebel
    Bruce Chesebro
    Journal of Neuroinflammation, 18
  • [47] Innate immune responses after stimulation with Toll-like receptor agonists in ex vivo microglial cultures and an in vivo model using mice with reduced microglia
    Carroll, James A.
    Race, Brent
    Williams, Katie
    Striebel, James F.
    Chesebro, Bruce
    JOURNAL OF NEUROINFLAMMATION, 2021, 18 (01)
  • [48] Nanoparticle-Delivered Multimeric Soluble CD40L DNA Combined with Toll-Like Receptor Agonists as a Treatment for Melanoma
    Stone, Geoffrey W.
    Barzee, Suzanne
    Snarsky, Victoria
    Santucci, Camila
    Tran, Brian
    Langer, Robert
    Zugates, Gregory T.
    Anderson, Daniel G.
    Kornbluth, Richard S.
    PLOS ONE, 2009, 4 (10):
  • [49] Evaluation of the adjuvant effect of agonists of toll-like receptor 4 and 7/8 in a vaccine against leishmaniasis in BALB/c mice
    Rostamian, Mosayeb
    Niknam, Hamid M.
    MOLECULAR IMMUNOLOGY, 2017, 91 : 202 - 208
  • [50] Stereochemistry and innate immune recognition: (+)-norbinaltorphimine targets myeloid differentiation protein 2 and inhibits toll-like receptor 4 signaling
    Zhang, Xiaozheng
    Peng, Yinghua
    Grace, Peter M.
    Metcalf, Matthew D.
    Kwilasz, Andrew J.
    Wang, Yibo
    Zhang, Tianshu
    Wu, Siru
    Selfridge, Brandon R.
    Portoghese, Philip S.
    Rice, Kenner C.
    Watkins, Linda R.
    Hutchinson, Mark R.
    Wang, Xiaohui
    FASEB JOURNAL, 2019, 33 (08): : 9577 - 9587